Pyxis Oncology annual current ratio
2020
2021
2022
2023
2024
2025
Pyxis Oncology Current Ratio Growth & History (PYXS)
Pyxis Oncology's current ratio was 3.41 for fiscal 2025.
View full Pyxis Oncology company overviewPyxis Oncology annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 3.41 | −4.08 | −54.45% |
| 2024 | 2024-12-31 | 7.49 | 2.65 | +54.86% |
| 2023 | 2023-12-31 | 4.84 | −1.06 | −18.00% |
| 2022 | 2022-12-31 | 5.90 | −9.00 | −60.40% |
| 2021 | 2021-12-31 | 14.90 | 12.70 | +578.16% |
| 2020 | 2020-12-31 | 2.20 | — | — |
Pyxis Oncology quarterly current ratio
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.34 | −4.32 | −76.35% |
| Q1 2026 | 2026-03-31 | 2.76 | −5.00 | −64.44% |
| Q4 2025 | 2025-12-31 | 3.41 | −4.08 | −54.45% |
| Q3 2025 | 2025-09-30 | 4.29 | −3.04 | −41.50% |
| Q2 2025 | 2025-06-30 | 5.65 | −3.88 | −40.67% |
| Q1 2025 | 2025-03-31 | 7.75 | −4.44 | −36.40% |
| Q4 2024 | 2024-12-31 | 7.49 | 2.65 | +54.86% |
| Q3 2024 | 2024-09-30 | 7.33 | 2.42 | +49.23% |
| Q2 2024 | 2024-06-30 | 9.53 | −6.65 | −41.11% |
| Q1 2024 | 2024-03-31 | 12.19 | −1.27 | −9.45% |
| Q4 2023 | 2023-12-31 | 4.84 | −1.06 | −18.00% |
| Q3 2023 | 2023-09-30 | 4.91 | −5.71 | −53.78% |
| Q2 2023 | 2023-06-30 | 16.18 | 0.99 | +6.54% |
| Q1 2023 | 2023-03-31 | 13.46 | 0.37 | +2.81% |
| Q4 2022 | 2022-12-31 | 5.90 | −9.00 | −60.40% |
| Q3 2022 | 2022-09-30 | 10.62 | 2.64 | +33.12% |
| Q2 2022 | 2022-06-30 | 15.19 | — | — |
| Q1 2022 | 2022-03-31 | 13.10 | — | — |
| Q4 2021 | 2021-12-31 | 14.90 | 12.70 | +578.16% |
| Q3 2021 | 2021-09-30 | 7.98 | — | — |
| Q4 2020 | 2020-12-31 | 2.20 | — | — |
Pyxis Oncology current ratio trends
Over the last five fiscal years, Pyxis Oncology's current ratio increased from 2.20 to 3.41, a change of 1.22. The latest reported quarter, Q2 2026, shows 1.34.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pyxis Oncology source filings ↗